State Street Corp Capricor Therapeutics, Inc. Call Options Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
141Shares Held
12.4MCall Options Held
4.99MPut Options Held
5.52M-
Vanguard Group Inc Valley Forge, PA2.31MShares$14.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$10 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$5.94 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$3.4 Million0.0% of portfolio
-
Ubs Group Ag549KShares$3.39 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $150M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...